Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""human immunodeficiency virus"" wg kryterium: Temat


Tytuł:
TAT peptide at treatment-level concentrations crossed brain endothelial cell monolayer independent of receptor-mediated endocytosis or peptide-inflicted barrier disruption.
Autorzy:
Wu MC; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; School of Chinese Medicine, China Medical University, Taichung, Taiwan.
Wang EY; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; School of Medicine, China Medical University, Taichung, Taiwan.
Lai TW; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.; School of Medicine, China Medical University, Taichung, Taiwan.; Neuroscience and Brain Disease Center, China Medical University, Taichung, Taiwan.; Drug Development Center, China Medical University, Taichung, Taiwan.; Translational Medicine Research Center, China Medical University Hospital, Taichung, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Oct 11; Vol. 18 (10), pp. e0292681. Date of Electronic Publication: 2023 Oct 11 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Endothelial Cells*/metabolism
tat Gene Products, Human Immunodeficiency Virus*/metabolism
Brain/metabolism ; Blood-Brain Barrier/metabolism ; Peptides/metabolism ; Endocytosis
Czasopismo naukowe
Tytuł:
Identification of viral protein R of human immunodeficiency virus-1 (HIV) and interleukin-6 as risk factors for malignancies in HIV-infected individuals: A cohort study.
Autorzy:
Matsunaga A; Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan.
Ando N; AIDS Clinical Center, Hospital, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan.
Yamagata Y; Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan.; RIKEN SPring-8 Center, Koto, Sayo, Hyogo, Japan.
Shimura M; Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan.; RIKEN SPring-8 Center, Koto, Sayo, Hyogo, Japan.
Gatanaga H; AIDS Clinical Center, Hospital, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan.
Oka S; AIDS Clinical Center, Hospital, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan.
Ishizaka Y; Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Toyama, Shinjuku, Tokyo, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 02; Vol. 19 (1), pp. e0296502. Date of Electronic Publication: 2024 Jan 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
HIV-1*
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/metabolism
Neoplasms*
Humans ; Interleukin-6 ; vpr Gene Products, Human Immunodeficiency Virus ; Cohort Studies ; Risk Factors ; Immunoglobulin G
Czasopismo naukowe
Tytuł:
HIV-1 release requires Nef-induced caspase activation.
Autorzy:
Segura J; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Ireland J; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Zou Z; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Roth G; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Buchwald J; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Shen TJ; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Fischer E; Research Technology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Sun PD; Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Feb 13; Vol. 18 (2), pp. e0281087. Date of Electronic Publication: 2023 Feb 13 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
MeSH Terms:
HIV Infections*/drug therapy
HIV Seropositivity*
HIV-1*/genetics
nef Gene Products, Human Immunodeficiency Virus*/metabolism
Humans ; Caspases/metabolism ; CD4-Positive T-Lymphocytes/metabolism ; Cell Death
Czasopismo naukowe
Tytuł:
Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides.
Autorzy:
Kardani K; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hashemi A; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Bolhassani A; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Oct 31; Vol. 14 (10), pp. e0223844. Date of Electronic Publication: 2019 Oct 31 (Print Publication: 2019).
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Cell-Penetrating Peptides/*metabolism
Epitopes, T-Lymphocyte/*metabolism
HIV-1/*immunology
Human Immunodeficiency Virus Proteins/*immunology
Viral Regulatory and Accessory Proteins/*metabolism
vif Gene Products, Human Immunodeficiency Virus/*metabolism
Amino Acid Sequence ; Epitopes, T-Lymphocyte/chemistry ; Epitopes, T-Lymphocyte/immunology ; HEK293 Cells ; HIV Core Protein p24/immunology ; HIV Envelope Protein gp160/immunology ; Human Immunodeficiency Virus Proteins/metabolism ; Humans ; nef Gene Products, Human Immunodeficiency Virus/immunology
Czasopismo naukowe
Tytuł:
Blockade of beta adrenergic receptors protects the blood brain barrier and reduces systemic pathology caused by HIV-1 Nef protein.
Autorzy:
Rivera-Ortiz J; HIV-1 Immunopathogenesis Laboratory, The Wistar Institute, Philadelphia, PA, United States of America.
Pla-Tenorio J; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico.
Cruz ML; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico.
Colon K; HIV-1 Immunopathogenesis Laboratory, The Wistar Institute, Philadelphia, PA, United States of America.
Perez-Morales J; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico.
Rodriguez JA Jr; Cooper University Hospital Department of Orthopaedic Surgery, Camden, NJ, United States of America.
Martinez-Sicari J; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico.
Noel RJ Jr; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Nov 16; Vol. 16 (11), pp. e0259446. Date of Electronic Publication: 2021 Nov 16 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Adrenergic beta-Antagonists/*pharmacology
Blood-Brain Barrier/*drug effects
nef Gene Products, Human Immunodeficiency Virus/*metabolism
Adrenergic beta-Antagonists/administration & dosage ; Animals ; Astrocytes/cytology ; Astrocytes/metabolism ; Blood-Brain Barrier/metabolism ; Brain/cytology ; Brain/metabolism ; Brain/pathology ; Cells, Cultured ; Claudin-5/genetics ; Claudin-5/metabolism ; Down-Regulation/drug effects ; Female ; HIV-1/metabolism ; Interleukin-1beta/blood ; Intestine, Small/metabolism ; Intestine, Small/pathology ; Lung/metabolism ; Lung/pathology ; Male ; Propranolol/administration & dosage ; Propranolol/pharmacology ; Rats ; Rats, Sprague-Dawley ; nef Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
A real-time assay for cell-penetrating peptide-mediated delivery of molecular cargos.
Autorzy:
Gentry SB; Department of Molecular & Cellular Biology, Kennesaw State University, Kennesaw, Georgia, United States of America.
Nowak SJ; Department of Molecular & Cellular Biology, Kennesaw State University, Kennesaw, Georgia, United States of America.
Ni X; School of Data Science & Analytics, Kennesaw State University, Kennesaw, Georgia, United States of America.
Hill SA; Department of Molecular & Cellular Biology, Kennesaw State University, Kennesaw, Georgia, United States of America.
Wade LR; Department of Molecular & Cellular Biology, Kennesaw State University, Kennesaw, Georgia, United States of America.
Clark WR; Department of Molecular & Cellular Biology, Kennesaw State University, Kennesaw, Georgia, United States of America.
Keelaghan AP; Department of Molecular & Cellular Biology, Kennesaw State University, Kennesaw, Georgia, United States of America.
Morris DP; Department of Molecular & Cellular Biology, Kennesaw State University, Kennesaw, Georgia, United States of America.
McMurry JL; Department of Molecular & Cellular Biology, Kennesaw State University, Kennesaw, Georgia, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Sep 02; Vol. 16 (9), pp. e0254468. Date of Electronic Publication: 2021 Sep 02 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Calmodulin/*metabolism
Cell-Penetrating Peptides/*chemistry
Drug Delivery Systems/*methods
Endosomes/*metabolism
Maltose-Binding Proteins/*metabolism
Small Molecule Libraries/*administration & dosage
tat Gene Products, Human Immunodeficiency Virus/*metabolism
Animals ; Biological Assay/methods ; Calmodulin/chemistry ; Cell Line ; Cricetinae ; Cytosol/metabolism ; Drug Delivery Systems/instrumentation ; Endosomes/drug effects ; Humans ; Microscopy, Fluorescence/methods ; Rats ; Small Molecule Libraries/chemistry ; tat Gene Products, Human Immunodeficiency Virus/chemistry
Czasopismo naukowe
Tytuł:
Intrinsic resistance of HIV-2 and SIV to the maturation inhibitor GSK2838232.
Autorzy:
Smith RA; Center for Emerging and Reemerging Infectious Diseases, University of Washington, Seattle, Washington, United States of America.; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America.
Raugi DN; Center for Emerging and Reemerging Infectious Diseases, University of Washington, Seattle, Washington, United States of America.; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America.
Nixon RS; Center for Emerging and Reemerging Infectious Diseases, University of Washington, Seattle, Washington, United States of America.; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America.
Song J; Center for Emerging and Reemerging Infectious Diseases, University of Washington, Seattle, Washington, United States of America.; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America.
Seydi M; Service des Maladies Infectieuses et Tropicales, CHNU de Fann, Dakar, Senegal.
Gottlieb GS; Center for Emerging and Reemerging Infectious Diseases, University of Washington, Seattle, Washington, United States of America.; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, United States of America.; Department of Global Health, University of Washington, Seattle, Washington, United States of America.
Pokaż więcej
Corporate Authors:
University of Washington-Senegal HIV-2 Study Group
Źródło:
PloS one [PLoS One] 2023 Jan 18; Vol. 18 (1), pp. e0280568. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Triterpenes*/pharmacology
HIV Seropositivity*
Anti-HIV Agents*/pharmacology
Humans ; Virus Replication ; HIV-2/genetics ; gag Gene Products, Human Immunodeficiency Virus/genetics ; Capsid Proteins/genetics ; Peptides/pharmacology
Czasopismo naukowe
Tytuł:
Mutational networks of escape from transmitted HIV-1 infection.
Autorzy:
Akand EH; School of Mathematics and Statistics, UNSW Sydney, Kensington, NSW, Australia.
Maher SJ; College of Engineering, Mathematical and Physical Sciences, University of Exeter, Exeter, United Kingdom.
Murray JM; School of Mathematics and Statistics, UNSW Sydney, Kensington, NSW, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Dec 07; Vol. 15 (12), pp. e0243391. Date of Electronic Publication: 2020 Dec 07 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Envelope Protein gp160/*genetics
HIV Infections/*genetics
HIV-1/*genetics
env Gene Products, Human Immunodeficiency Virus/*genetics
Computational Biology ; Glycosylation ; HIV Envelope Protein gp160/immunology ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/pathogenicity ; Humans ; Immune Evasion/genetics ; Immunity/genetics ; Immunity/immunology ; Mutation/genetics ; Protein Binding/genetics ; env Gene Products, Human Immunodeficiency Virus/immunology
Czasopismo naukowe
Tytuł:
A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity.
Autorzy:
González-Feliciano JA; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.
Akamine P; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.
Capó-Vélez CM; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.
Delgado-Vélez M; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.
Dussupt V; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Krebs SJ; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.
Wojna V; Division of Neurology, Internal Medicine Department and NeuroHIV Research Program, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Polonis VR; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Baerga-Ortiz A; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.; Department of Biochemistry, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico.
Lasalde-Dominicci JA; Molecular Sciences Research Center Inc., University of Puerto Rico, San Juan, Puerto Rico.; Department of Biology, University of Puerto Rico, Rio Piedras Campus, San Juan, Puerto Rico.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Jun 19; Vol. 15 (6), pp. e0231679. Date of Electronic Publication: 2020 Jun 19 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Glycopeptides/*analysis
HIV Antibodies/*immunology
HIV-1/*metabolism
env Gene Products, Human Immunodeficiency Virus/*immunology
Adult ; Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Antigen-Antibody Reactions ; CHO Cells ; Cricetinae ; Cricetulus ; Female ; Glycosylation ; HEK293 Cells ; Humans ; Middle Aged ; Recombinant Proteins/biosynthesis ; Recombinant Proteins/immunology ; Recombinant Proteins/isolation & purification ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Young Adult ; env Gene Products, Human Immunodeficiency Virus/genetics ; env Gene Products, Human Immunodeficiency Virus/metabolism
Czasopismo naukowe
Tytuł:
HIV-1 pol gene diversity and molecular dating of subtype C from Sri Lanka.
Autorzy:
Patil A; HIV Drug Resistance Laboratory, National AIDS Research Institute, Pune, India.
Elwitigala JP; National STD/AIDS Control Programme, Colombo, Sri Lanka.
Rajapaksa L; National STD/AIDS Control Programme, Colombo, Sri Lanka.
Gangakhedkar R; Indian Council of Medical Research, New Delhi, India.
Chaturbhuj D; Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
Pendse R; World Health Organization, Colombo, Sri Lanka.
Rajapaksha DI; National STD/AIDS Control Programme, Colombo, Sri Lanka.
Rewari BB; World Health Organization South-East Asia Region, New Delhi, India.
Malliawadu N; National STD/AIDS Control Programme, Colombo, Sri Lanka.
Jayamanna K; National STD/AIDS Control Programme, Colombo, Sri Lanka.
Dombawela D; National STD/AIDS Control Programme, Colombo, Sri Lanka.
Kurle S; HIV Drug Resistance Laboratory, National AIDS Research Institute, Pune, India.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Jun 11; Vol. 15 (6), pp. e0234133. Date of Electronic Publication: 2020 Jun 11 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Variation*
HIV-1/*metabolism
pol Gene Products, Human Immunodeficiency Virus/*genetics
Adolescent ; Adult ; Aged ; Anti-Retroviral Agents/therapeutic use ; Bayes Theorem ; Child ; Child, Preschool ; Drug Resistance, Viral/genetics ; Female ; HIV Infections/drug therapy ; HIV Infections/epidemiology ; HIV Infections/pathology ; Humans ; Male ; Middle Aged ; Mutation ; Phylogeny ; Sri Lanka/epidemiology ; Young Adult ; pol Gene Products, Human Immunodeficiency Virus/chemistry ; pol Gene Products, Human Immunodeficiency Virus/classification
Czasopismo naukowe
Tytuł:
Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells.
Autorzy:
Cupo A; Weill Cornell Medical College, New York, New York, United States of America.
Cruz Portillo VM; Weill Cornell Medical College, New York, New York, United States of America.
Gelfand P; Weill Cornell Medical College, New York, New York, United States of America.
Yasmeen A; Weill Cornell Medical College, New York, New York, United States of America.
Klasse PJ; Weill Cornell Medical College, New York, New York, United States of America.
Moore JP; Weill Cornell Medical College, New York, New York, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Apr 08; Vol. 14 (4), pp. e0215106. Date of Electronic Publication: 2019 Apr 08 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Antibodies, Monoclonal/*metabolism
Chromatography, Affinity/*methods
Chromatography, Affinity/*standards
env Gene Products, Human Immunodeficiency Virus/*chemistry
env Gene Products, Human Immunodeficiency Virus/*isolation & purification
Animals ; Antibodies, Monoclonal/immunology ; Cricetinae ; Cricetulus ; Humans ; Protein Multimerization ; env Gene Products, Human Immunodeficiency Virus/immunology ; env Gene Products, Human Immunodeficiency Virus/metabolism
Czasopismo naukowe
Tytuł:
Investigation of HIV-1 Gag binding with RNAs and lipids using Atomic Force Microscopy.
Autorzy:
Chen S; Department of Physics & Astronomy, University of California, Riverside, California, United States of America.
Xu J; Department of Physics & Astronomy, University of California, Riverside, California, United States of America.
Liu M; Department of Physics & Astronomy, University of California, Riverside, California, United States of America.
Rao ALN; Department of Plant Pathology & Microbiology, University of California, Riverside, California, United States of America.
Zandi R; Department of Physics & Astronomy, University of California, Riverside, California, United States of America.
Gill SS; Department of Cell Biology & Neuroscience, University of California, Riverside, California, United States of America.
Mohideen U; Department of Physics & Astronomy, University of California, Riverside, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Feb 03; Vol. 15 (2), pp. e0228036. Date of Electronic Publication: 2020 Feb 03 (Print Publication: 2020).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections/*genetics
HIV-1/*genetics
RNA, Viral/*genetics
gag Gene Products, Human Immunodeficiency Virus/*ultrastructure
Cell Membrane/chemistry ; Cell Membrane/genetics ; HIV Infections/virology ; HIV Seropositivity ; HIV-1/chemistry ; HIV-1/pathogenicity ; Humans ; Lipids/chemistry ; Microscopy, Atomic Force ; Multiprotein Complexes/chemistry ; Multiprotein Complexes/genetics ; Phosphatidylinositol 4,5-Diphosphate/chemistry ; Protein Binding ; Protein Multimerization/genetics ; RNA, Viral/chemistry ; RNA-Binding Proteins/chemistry ; RNA-Binding Proteins/genetics ; gag Gene Products, Human Immunodeficiency Virus/chemistry ; gag Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens.
Autorzy:
Li SW; Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California, United States of America.; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Wright M; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Healey JF; Department of Pediatrics, Emory University, Atlanta, Georgia, United States of America.
Hutchinson JM; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
O'Rourke S; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Mesa KA; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Lollar P; Department of Pediatrics, Emory University, Atlanta, Georgia, United States of America.
Berman PW; Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 May 29; Vol. 15 (5), pp. e0233866. Date of Electronic Publication: 2020 May 29 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Editing*
Proteolysis*
AIDS Vaccines/*immunology
env Gene Products, Human Immunodeficiency Virus/*immunology
Alleles ; Amino Acid Sequence ; Animals ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/immunology ; Binding Sites ; CHO Cells ; Consensus Sequence ; Cricetinae ; Cricetulus ; Factor VIII/metabolism ; Glycosylation ; Humans ; Polysaccharides/metabolism ; Protein Domains ; Recombinant Proteins/metabolism ; Serine Proteases/chemistry ; Serine Proteases/metabolism ; Structural Homology, Protein ; Substrate Specificity ; Thrombin/metabolism ; env Gene Products, Human Immunodeficiency Virus/chemistry
Czasopismo naukowe
Tytuł:
m6A minimally impacts the structure, dynamics, and Rev ARM binding properties of HIV-1 RRE stem IIB.
Autorzy:
Chu CC; Department of Biochemistry, Duke University School of Medicine, Durham, NC, United States of America.
Liu B; Department of Biochemistry, Duke University School of Medicine, Durham, NC, United States of America.
Plangger R; Institute of Organic Chemistry and Center for Molecular Biosciences CMBI, Universität Innsbruck, Innsbruck, Austria.
Kreutz C; Institute of Organic Chemistry and Center for Molecular Biosciences CMBI, Universität Innsbruck, Innsbruck, Austria.
Al-Hashimi HM; Department of Biochemistry, Duke University School of Medicine, Durham, NC, United States of America.; Department of Chemistry, Duke University, Durham, NC, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Dec 11; Vol. 14 (12), pp. e0224850. Date of Electronic Publication: 2019 Dec 11 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Response Elements*
Adenosine/*analogs & derivatives
RNA, Viral/*chemistry
RNA, Viral/*metabolism
rev Gene Products, Human Immunodeficiency Virus/*chemistry
rev Gene Products, Human Immunodeficiency Virus/*metabolism
Adenosine/chemistry ; Base Pairing ; Base Sequence ; Humans ; Models, Molecular ; Nuclear Magnetic Resonance, Biomolecular ; Nucleic Acid Conformation ; Protein Binding ; RNA, Viral/genetics ; rev Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting.
Autorzy:
King HAD; Disease Elimination, Burnet Institute, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Gonelli CA; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Tullett KM; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
Lahoud MH; Disease Elimination, Burnet Institute, Melbourne, Victoria, Australia.; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria, Australia.
Purcell DFJ; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Drummer HE; Disease Elimination, Burnet Institute, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.; Department of Microbiology, Monash University, Melbourne, Victoria, Australia.
Poumbourios P; Disease Elimination, Burnet Institute, Melbourne, Victoria, Australia.; Department of Microbiology, Monash University, Melbourne, Victoria, Australia.
Center RJ; Disease Elimination, Burnet Institute, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Aug 20; Vol. 14 (8), pp. e0220986. Date of Electronic Publication: 2019 Aug 20 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
AIDS Vaccines/*immunology
HIV Infections/*therapy
Recombinant Fusion Proteins/*immunology
Single-Chain Antibodies/*immunology
env Gene Products, Human Immunodeficiency Virus/*immunology
AIDS Vaccines/administration & dosage ; AIDS Vaccines/genetics ; Animals ; Antibodies, Neutralizing/immunology ; Antibody Affinity ; Antigens, Viral/genetics ; Antigens, Viral/immunology ; Dendritic Cells/immunology ; Dendritic Cells/metabolism ; Epitopes/immunology ; Female ; HEK293 Cells ; HIV Antibodies/immunology ; HIV Infections/immunology ; HIV Infections/virology ; Humans ; Immunogenicity, Vaccine ; Lectins, C-Type/immunology ; Lectins, C-Type/metabolism ; Mice ; Proof of Concept Study ; Protein Domains/genetics ; Protein Domains/immunology ; Receptors, Mitogen/immunology ; Receptors, Mitogen/metabolism ; Recombinant Fusion Proteins/administration & dosage ; Recombinant Fusion Proteins/genetics ; Single-Chain Antibodies/administration & dosage ; Single-Chain Antibodies/genetics ; Vaccination/methods ; Vaccines, DNA/administration & dosage ; Vaccines, DNA/genetics ; Vaccines, DNA/immunology ; env Gene Products, Human Immunodeficiency Virus/administration & dosage ; env Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.
Autorzy:
Cheng C; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Xu K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Kong R; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Chuang GY; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Corrigan AR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Geng H; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Hill KR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Jafari AJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
O'Dell S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Ou L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Rawi R; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Rowshan AP; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Sarfo EK; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Sastry M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Saunders KO; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
Schmidt SD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Wang S; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Wu W; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Zhang B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Doria-Rose NA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Haynes BF; Duke Human Vaccine Institute, Duke School of Medicine, Durham, North Carolina, United States of America.
Scorpio DG; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Shapiro L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York, United States of America.
Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Apr 17; Vol. 14 (4), pp. e0215163. Date of Electronic Publication: 2019 Apr 17 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Immunization, Secondary*
AIDS Vaccines/*immunology
Antibodies, Neutralizing/*immunology
HIV Antibodies/*immunology
HIV Infections/*immunology
HIV-1/*immunology
Peptides/*pharmacokinetics
env Gene Products, Human Immunodeficiency Virus/*immunology
AIDS Vaccines/genetics ; AIDS Vaccines/pharmacokinetics ; Animals ; Guinea Pigs ; HIV Infections/prevention & control ; HIV-1/genetics ; Peptides/genetics ; Peptides/immunology ; env Gene Products, Human Immunodeficiency Virus/genetics ; env Gene Products, Human Immunodeficiency Virus/pharmacology
Czasopismo naukowe
Tytuł:
Identification of a novel CDK9 inhibitor targeting the intramolecular hidden cavity of CDK9 induced by Tat binding.
Autorzy:
Asamitsu K; Department of Neurocognitive Science, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Hirokawa T; Division of Biomedical Science, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaragi, Japan.; Transborder Medical Research Center, University of Tsukuba, Tsukuba, Ibaragi, Japan.
Okamoto T; Department of Neurocognitive Science, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Nov 15; Vol. 17 (11), pp. e0277024. Date of Electronic Publication: 2022 Nov 15 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cyclin-Dependent Kinase 9*/metabolism
HIV-1*/genetics
Positive Transcriptional Elongation Factor B/metabolism ; tat Gene Products, Human Immunodeficiency Virus/metabolism ; Cyclin T/chemistry ; Cyclin-Dependent Kinase Inhibitor Proteins ; Transcription, Genetic
Czasopismo naukowe
Tytuł:
Selective transmission of some HIV-1 subtype C variants might depend on Envelope stimulating dendritic cells to secrete IL-10.
Autorzy:
Lumngwena EN; Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Institute for Medical Research and Medicinal Plants studies (IMPM), Ministry of Scientific Research and Innovation (MINRESI), Yaounde, Cameroon.
Abrahams B; Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Shuping L; National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Cicala C; National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, United States of America.
Arthos J; National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, Maryland, United States of America.
Woodman Z; Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Jan 24; Vol. 15 (1), pp. e0227533. Date of Electronic Publication: 2020 Jan 24 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Variation*
Dendritic Cells/*metabolism
Dendritic Cells/*virology
HIV-1/*genetics
HIV-1/*physiology
Interleukin-10/*metabolism
env Gene Products, Human Immunodeficiency Virus/*genetics
Cell Adhesion Molecules/metabolism ; Dendritic Cells/immunology ; Female ; Glycosylation ; HEK293 Cells ; HIV-1/immunology ; Humans ; Lectins, C-Type/metabolism ; Phenotype ; Receptors, Cell Surface/metabolism ; Vaccines, DNA/immunology ; Virus Internalization ; env Gene Products, Human Immunodeficiency Virus/metabolism
Czasopismo naukowe
Tytuł:
Infusion of HIV-1 Nef-expressing astrocytes into the rat hippocampus induces enteropathy and interstitial pneumonitis and increases blood-brain-barrier permeability.
Autorzy:
Rivera J; HIV-1 Immunopathogenesis Laboratory, The Wistar Institute, Philadelphia, PA, United States of America.
Isidro RA; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico, United States of America.
Loucil-Alicea RY; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico, United States of America.
Cruz ML; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico, United States of America.
Appleyard CB; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico, United States of America.
Isidro AA; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico, United States of America.
Chompre G; Department of Biology, Pontifical Catholic University of Puerto Rico, Ponce, Puerto Rico, United States of America.
Colon-Rivera K; HIV-1 Immunopathogenesis Laboratory, The Wistar Institute, Philadelphia, PA, United States of America.
Noel RJ Jr; Department of Basic Sciences, Ponce Health Sciences University, Ponce Research Institute, Ponce, Puerto Rico, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Nov 27; Vol. 14 (11), pp. e0225760. Date of Electronic Publication: 2019 Nov 27 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Astrocytes/*transplantation
Blood-Brain Barrier/*pathology
Hippocampus/*pathology
Lung Diseases, Interstitial/*etiology
Neurons/*pathology
nef Gene Products, Human Immunodeficiency Virus/*metabolism
Animals ; Astrocytes/metabolism ; Blood-Brain Barrier/metabolism ; Cells, Cultured ; Hippocampus/metabolism ; Interleukin-1beta/metabolism ; Lung Diseases, Interstitial/pathology ; Macrophages/metabolism ; Macrophages/pathology ; Male ; Neurons/metabolism ; Rats ; Rats, Sprague-Dawley ; nef Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Tytuł:
Specific inter-domain interactions stabilize a compact HIV-1 Gag conformation.
Autorzy:
Lin C; Department of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, CA, United States of America.
Mendoza-Espinosa P; Departamento de Física, Universidad Autónoma Metropolitana, Iztapalapa, Ciudad de México, México.
Rouzina I; Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, United States of America.
Guzmán O; Departamento de Física, Universidad Autónoma Metropolitana, Iztapalapa, Ciudad de México, México.
Moreno-Razo JA; Departamento de Física, Universidad Autónoma Metropolitana, Iztapalapa, Ciudad de México, México.
Francisco JS; Department of Chemistry, The University of Pennsylvania, Philadelphia, PA, United States of America.
Bruinsma R; Department of Physics and Astronomy, University of California Los Angeles, Los Angeles, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Aug 22; Vol. 14 (8), pp. e0221256. Date of Electronic Publication: 2019 Aug 22 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Capsid/*ultrastructure
HIV-1/*ultrastructure
RNA, Viral/*chemistry
Virion/*ultrastructure
gag Gene Products, Human Immunodeficiency Virus/*chemistry
Amino Acid Motifs ; Binding Sites ; Capsid/metabolism ; HIV-1/metabolism ; Humans ; Kinetics ; Molecular Dynamics Simulation ; Phytic Acid/chemistry ; Phytic Acid/metabolism ; Protein Binding ; Protein Conformation, alpha-Helical ; Protein Interaction Domains and Motifs ; Protein Multimerization ; RNA, Viral/metabolism ; Static Electricity ; Thermodynamics ; Virion/metabolism ; Virus Assembly ; gag Gene Products, Human Immunodeficiency Virus/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies